BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Business

  Diakonos Oncology Appoints Biotech Veteran Anthony Baldor as Chief Financial Officer

  Diakonos Oncology Corp., a clinical stage immuno-oncology company, announced that Anthony Baldor has been appointed Chief Financial Officer.

  February 26, 2024

   · 

  2 min read
• BioMidwest

  Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference

  Biodesix, Inc. announced that Scott Hutton, Chief Executive Officer of Biodesix, will present and host in-person 1x1 investor meetings at the TD Cowen 44th Annual Health Care Conference, which will be held from March 4-6, 2024.

  February 26, 2024

   · 

  3 min read
• Genetown

  Apellis Pharmaceuticals to Present at Upcoming March 2024 Investor Conferences

  Apellis Pharmaceuticals, Inc., announced that the company will participate in the following March investor conferences.

  February 26, 2024

   · 

  1 min read
• Microbix Announces Issuance of Stock Options - February 26, 2024

  Microbix Biosystems Inc. announces the issuance of stock options under its shareholder-approved 2018 stock option plan, as part of its compensation programs to incentivize and retain its board of directors, executives, and managers.

  February 26, 2024

   · 

  5 min read
• Genetown

  Voyager Therapeutics Announces Selection of Gene Therapy Development Candidate for Friedreich’s Ataxia in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment

  Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced that the joint steering committee with its collaborator Neurocrine Biosciences has selected a lead development candidate in the Friedreich’s ataxia (FA) program.

  February 26, 2024

   · 

  6 min read
• Business

  BioCryst Reports Fourth Quarter and Full Year 2023 Financial Results and Upcoming Key Milestones

  BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided a corporate update.

  February 26, 2024

   · 

  15 min read
• Compugen to Present at the Leerink Partners Global Biopharma Conference 2024

  Compugen Ltd. today announced that management will participate in a fireside chat at the Leerink Partners Global Biopharma Conference, Miami Beach, Florida, on Monday, March 11, 2024 at 11:20 AM ET.

  February 26, 2024

   · 

  2 min read
• Pharm Country

  Cognition Therapeutics to Present at the TD Cowen Health Care Conference

  Cognition Therapeutics, Inc. announced today that the Company’s president and CEO, Lisa Ricciardi will present at the TD Cowen 44th Annual Health Care Conference taking place March 4-6, 2024.

  February 26, 2024

   · 

  5 min read
• Biotech Bay

  GeminiBio launches human serum AB product for global cell therapy market

  Gemini Bioproducts, LLC today announced the launch of a new human AB serum product for the cell therapy and regenerative medicine markets.

  February 26, 2024

   · 

  3 min read
• Biotech Bay

  Aligos Therapeutics To Participate in the Leerink Partners Global Biopharma Conference 2024

  Aligos Therapeutics, Inc. today announced that management will participate in one-on-one meetings at the Leerink Partners Global Biopharma Conference 2024 being held in Miami, Florida on March 11-13, 2024.

  February 26, 2024

   · 

  1 min read